“…Ongoing P. vivax research gaps in Peru include the following: identification of asymptomatic parasitemics, quantification of the contribution of patent and subpatent parasitemics to mosquito transmission, diagnosis of nonparasitemic hypnozoite carriers, and implementation of surveillance for potential emergence of chloroquine- and 8-aminoquinoline-resistant P. vivax. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To explore whether gene expression profiling can identify a molecular mechanism for the clinical benefit of canakinumab treatment in patents with tumour necrosis factor receptor-associated periodic syndrome (TRAPS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The limited facilities of radioisotope tracer and isosulfan or patent blue dye (PBD) have been the major obstacles to perform sentinel node biopsy (SNB) in our country. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Employing a previously characterized and patented biosensor system evaluating hepatocyte toxicity in vitro, human hepatocellular carcinoma cells (HepG2/C3A) were exposed to 0.01–50 ng/mL procalcitonin for 2 × 72 h and evaluated for proliferation, necrosis, metabolic activity, cellular integrity, microalbumin synthesis, and detoxification capacity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this study, we compared the advantages and disadvantages of our developed patented method with those of commonly used conventional methods (Ficoll-400, 1077, and handpicking methods). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…One patient had the stent patent at the time of last follow-up. Two patients with stent blockage at 35 d and 44 d after procedure underwent percutaneous transhepatic drain insertion only. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The left internal mammary artery was patent and other natives were the same as they had been 3 years ago. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Approval for the treatment of pulmonary arterial hypertension (PAH) was based on Phase III data from the PATENT studies, in which riociguat significantly improved exercise capacity, pulmonary vascular resistance, a range of secondary end points, and hemodynamic parameters in patients with symptomatic PAH. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DISCUSSION: The clean-tip catheter CSS enabled a more patent airway than its counterpart device that did not have this feature. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSIONS: Our patients with a C2-7 SVA of ≥35 mm maintained cervical regional balance after laminoplasty and their improvement in myelopathy was equivalent to that in patients with a C2-7 SVA of <35 mm. However, the patents with a C2-7 SVA of ≥35 mm experienced severe postoperative neck pain. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Moreover, some structural changes in cardiac and vascular tissues are also patent even before any systemic cardiovascular alterations.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The consortium was deposited in the Culture Collection of Algae and Protozoa (CCAP), an international depository authority for microalgal patents, as CCAP 293/1. This material has been successfully cryopreserved using a two-step cryopreservation protocol with dimethyl sulphoxide (5% v/v) used as a cryoprotectant. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…An ultrasonic flow meter and magnetic resonance imaging (MRI) showed that no cerebral ischemic lesions with patent ICA blood flow was were observed in animals receiving a ×10 of the standard dose of MSCs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OUTCOME: After the operation, a satisfactory velocity was confirmed 1 month postoperatively and the shunt still remained patent at the 6-month postoperation follow-up. LESSONS: A Meso-Rex bypass intervention connecting the left portal vein to the splenic vein instead of the superior mesenteric vein after liver transplantation in an adult patient with right and common portal vein occlusions has been successfully performed as an alternative approach.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All visible branches covered by the FD were patent. All patients were clinically assessed as having attained a favorable outcome (modified Rankin Scale score ≤ 2) at discharge and follow-up. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The intractable pain persisted and endoscopic ultrasound (EUS)-guided thrombolysis was planned. A window of patent superior mesenteric vein (SMV) was selected for EUS-guided puncture. …”
Enlace del recurso
Enlace del recurso

“…CONCLUSION: The operation was successful and on subsequent monthly reviews of the patient, she has a patent functional vagina of about 9 cm in length at 8 months after the operation with resumption of sexual intercourse.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In addition, the fetus in case 1 showed a patent ductus arteriosus, and the fetus in case 2 showed arterial duct agenesis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This, and the fact that it could not be patented in the USA, its largest potential market, meant that ICI nearly stopped the project. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The artery embolisms involved the cerebral artery (7 patients), renal artery (2 patients), mesentery artery (2 patients), popliteal artery (1 patient), descending aorta thrombus (1 patient), and thrombus-straddled patent foramen ovale (PFO) (1 patient). PFO was found in 3 cases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso